Recent Advancements and treatments in Recurrent Spontaneous Abortion : An Overview

Two or more successive pregnancy losses before the 20th week of pregnancy are referred to as recurrent spontaneous abortion (RSA). Recurrent spontaneous abortion has an etiology that is mostly unknown, multifactorial, with a lot of discussion about diagnosis and care. In this review we talked about the causes and the method to treat recurrent spontaneous abortion (RSA). Anatomical, gastrointestinal, and placental disorder, hormone concerns, illness, cigarettes and alcohol consumption environmental conditions, mental illnesses and traumatic life experiences, as well as some coagulation and protein deficiency responsible for immune system control, are all logical etiologic triggers.

In addition, the immune response plays an important role in human reproduction. Infertility, polycystic ovary syndrome, IVF success, obstetrical success, and male gonadal function have all been linked to vitamin-D. Low vitamin-D levels can boost the risk of obstetric problems during pregnancy. The majority of (RSA) cases, however, are undescribed, which can be attributed to autoimmune and isoimmune antibodies, which could play a role in pregnancy immunologic failure and abortion. The ability to recognize pregnancy immunologically is critical for the continuation of pregnancy. Anti-HLA antibodies may be prevented by inadequate identification of antigens from an unborn child or increased HLA exchange with the parent. Abortion is linked to lower levels of antiidiotypic antibodies (Ab2), anti-paternal cytotoxic antibodies (APCA), and mixed lymphocyte reaction blocking antibodies (MLR-Bf) in women with (RSA), according to several reports.

Thrombolytic therapies such as aspirin as well as heparin, intravenous immunoglobulin (IVIg) treatment, lymphocyte vaccination with parental lymphocytes, and newly used (RSA) drugs are all efficient.